Viewing StudyNCT00113113



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00113113
Status: COMPLETED
Last Update Posted: 2013-01-23
First Post: 2005-06-03

Brief Title: Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
Sponsor: Astex Pharmaceuticals Inc
Organization: Astex Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Tumors
Keywords:
Name View
RFS 2000 View
rubitecan View
Orathecin View
9-nitrocamptothecin View
solid tumors View
organ dysfunction View
renal dysfunction View
hepatic dysfunction View